Neuphoria Therapeutics Financial Ratios for Analysis 2021-2025 | NEUP

Fifteen years of historical annual and quarterly financial ratios and margins for Neuphoria Therapeutics (NEUP).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024202320222021
3.454.8712.4613.10
--0.010.01
--0.010.02
--100.00-
---8,309.63-
---8,309.63-
---7,888.81-
---8,326.38-
---8,253.62-
--0.00-
----
--0.04-
--9,393-
-88.58-97.14-38.23-18.27
-464.83-297.54-63.61-34.44
-56.03-74.86-33.32-16.03
-88.58-97.14-37.88-18.01
15.8532.3865.9276.27
-17.65-21.53-25.20-15.61
-17.65-21.53-25.00-15.54

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-12-312024-09-302024-06-302023-09-302023-06-302022-12-312022-06-302021-06-30
2.063.30------
--------
--------
100.00-------
-558.84-------
-558.84-------
--------
-291.49-------
-293.24-------
0.04-------
--------
18.64-------
4.83-------
-14.14-4.71------
-949.98-28.09------
-10.70-3.51------
-14.14-4.71------
8.4411.83------
-4.95-3.410.00-6.400.000.000.000.00
-4.95-3.41--6.40----